BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 30821959)

  • 1. Inhibition of the Alanine-Serine-Cysteine-1 Transporter by BMS-466442.
    Torrecillas IR; Conde-Ceide S; de Lucas AI; Garcı A Molina A; Trabanco AA; Lavreysen H; Pardo L; Tresadern G
    ACS Chem Neurosci; 2019 May; 10(5):2510-2517. PubMed ID: 30821959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Characterization of a small molecule inhibitor of the alanine serine cysteine transporter -1 (SLC7A10).
    Brown JM; Hunihan L; Prack MM; Harden DG; Bronson J; Dzierba CD; Gentles RG; Hendricson A; Krause R; Macor JE; Westphal RS
    J Neurochem; 2014 Apr; 129(2):275-83. PubMed ID: 24266811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain.
    Helboe L; Egebjerg J; Møller M; Thomsen C
    Eur J Neurosci; 2003 Oct; 18(8):2227-38. PubMed ID: 14622183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.
    Ndaru E; Garibsingh RA; Shi Y; Wallace E; Zakrepine P; Wang J; Schlessinger A; Grewer C
    J Gen Physiol; 2019 Mar; 151(3):357-368. PubMed ID: 30718375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Na(+) -Independent alanine-serine-cysteine transporter 1 inhibitor inhibits both influx and efflux of D-Serine.
    Sakimura K; Nakao K; Yoshikawa M; Suzuki M; Kimura H
    J Neurosci Res; 2016 Oct; 94(10):888-95. PubMed ID: 27302861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuronal role of the Alanine-Serine-Cysteine-1 transporter (SLC7A10, Asc-1) for glycine inhibitory transmission and respiratory pattern.
    Mesuret G; Khabbazzadeh S; Bischoff AM; Safory H; Wolosker H; Hülsmann S
    Sci Rep; 2018 Jun; 8(1):8536. PubMed ID: 29867218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity.
    Oppedisano F; Catto M; Koutentis PA; Nicolotti O; Pochini L; Koyioni M; Introcaso A; Michaelidou SS; Carotti A; Indiveri C
    Toxicol Appl Pharmacol; 2012 Nov; 265(1):93-102. PubMed ID: 23010140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asc-1 Transporter (SLC7A10): Homology Models And Molecular Dynamics Insights Into The First Steps Of The Transport Mechanism.
    Mikou A; Cabayé A; Goupil A; Bertrand HO; Mothet JP; Acher FC
    Sci Rep; 2020 Feb; 10(1):3731. PubMed ID: 32111919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine is not a substrate but a specific modulator of human ASCT2 (SLC1A5) transporter.
    Scalise M; Pochini L; Pingitore P; Hedfalk K; Indiveri C
    FEBS Lett; 2015 Nov; 589(23):3617-23. PubMed ID: 26492990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons.
    Ehmsen JT; Liu Y; Wang Y; Paladugu N; Johnson AE; Rothstein JD; du Lac S; Mattson MP; Höke A
    Sci Rep; 2016 Oct; 6():35592. PubMed ID: 27759100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling.
    Oppedisano F; Galluccio M; Indiveri C
    Biochem Pharmacol; 2010 Oct; 80(8):1266-73. PubMed ID: 20599776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating d-serine reuptake in the mouse CNS.
    Rutter AR; Fradley RL; Garrett EM; Chapman KL; Lawrence JM; Rosahl TW; Patel S
    Eur J Neurosci; 2007 Mar; 25(6):1757-66. PubMed ID: 17432963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dibasic amino acid interactions with Na+-independent transport system asc in horse erythrocytes. Kinetic evidence of functional and structural homology with Na+-dependent system ASC.
    Fincham DA; Mason DK; Young JD
    Biochim Biophys Acta; 1988 Jan; 937(1):184-94. PubMed ID: 3334844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2.
    Singh K; Tanui R; Gameiro A; Eisenberg G; Colas C; Schlessinger A; Grewer C
    Bioorg Med Chem Lett; 2017 Feb; 27(3):398-402. PubMed ID: 28057420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening.
    Colas C; Grewer C; Otte NJ; Gameiro A; Albers T; Singh K; Shere H; Bonomi M; Holst J; Schlessinger A
    PLoS Comput Biol; 2015 Oct; 11(10):e1004477. PubMed ID: 26444490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency.
    Schulte ML; Dawson ES; Saleh SA; Cuthbertson ML; Manning HC
    Bioorg Med Chem Lett; 2015 Jan; 25(1):113-6. PubMed ID: 25435145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS).
    Lee NY; Kim Y; Ryu H; Kang YS
    Biochem Biophys Res Commun; 2017 Jan; 483(1):135-141. PubMed ID: 28043791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport.
    Scalise M; Pochini L; Console L; Pappacoda G; Pingitore P; Hedfalk K; Indiveri C
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5.
    Scopelliti AJ; Font J; Vandenberg RJ; Boudker O; Ryan RM
    Nat Commun; 2018 Jan; 9(1):38. PubMed ID: 29295993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput Screening.
    Kutchukian PS; Warren L; Magliaro BC; Amoss A; Cassaday JA; O'Donnell G; Squadroni B; Zuck P; Pascarella D; Culberson JC; Cooke AJ; Hurzy D; Schlegel KS; Thomson F; Johnson EN; Uebele VN; Hermes JD; Parmentier-Batteur S; Finley M
    ACS Chem Biol; 2017 Feb; 12(2):519-527. PubMed ID: 28032990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.